Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma · 2023-07 · Volume 10 · 1069-1083
DOI: 10.2147/jhc.s411806 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Hepatocellular Carcinoma, 2023-07. Verfasst von Meng Tao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
- Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, People's Republic of China.
ORCID-Profile: Kai Wen, Weidong Wang, Sintim Mui
Zitieren
APA
Tao, M., Han, J., Shi, J., Liao, H., Wen, K., Wang, W., Mui, S., Li, H., Yan, Y., & Xiao, Z. (2023). Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma, Volume 10, 1069-1083. https://doi.org/10.2147/jhc.s411806
Vancouver
Tao M, Han J, Shi J, Liao H, Wen K, Wang W, et al. Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. 2023;Volume 10:1069-1083. doi:10.2147/jhc.s411806
BibTeX
@article{Tao2023,
author = {Tao, Meng and Han, Jing and Shi, Juanyi and Liao, Hao and Wen, Kai and Wang, Weidong and Mui, Sintim and Li, Huoming and Yan, Yongcong and Xiao, Zhiyu},
title = {Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma},
journal = {Journal of Hepatocellular Carcinoma},
year = {2023},
volume = {Volume 10},
pages = {1069--1083},
doi = {10.2147/jhc.s411806}
}
EUVIMED